Inventor · disambiguated record
Tsutomu Yoshikawa
Also filed as: YOSHIKAWA TSUTOMU
7 granted patents·6 pending applications·389 citations·filing 1999–2019
88Inventor score
Files withRES ASS FOR BIOTECHNOLOGY6MITSUBISHI TANABE PHARMA CORP3ACCELERON PHARMA INC2MITSUBISHI PHARMA CORP1WELFIDE CORP1
Top patents by PatentIndex Score
13 records- 0196US6943241B2Full-length cDNARES ASS FOR BIOTECHNOLOGY·Filed 2002·Granted Sep 13, 2005·160 cites·4 claims
- 0295US7193069B2Full-length cDNARES ASS FOR BIOTECHNOLOGY·Filed 2002·Granted Mar 20, 2007·105 cites·5 claims
- 0394US6979557B2Full-length cDNARES ASS FOR BIOTECHNOLOGY·Filed 2002·Granted Dec 27, 2005·80 cites·7 claims
- 0491US9758578B2Human anti-IL-33 neutralizing monoclonal antibodyMITSUBISHI TANABE PHARMA CORP·Filed 2014·Granted Sep 12, 2017·15 cites·20 claims
- 0569US11725049B2Human anti-IL-33 neutralizing monoclonal antibodyMITSUBISHI TANABE PHARMA CORP·Filed 2019·Granted Aug 15, 2023·0 cites·23 claims
- 0667US6528514B1IgE antibody production inhibitors and autoimmune diseases inhibitorsWELFIDE CORP·Filed 1999·Granted Mar 4, 2003·29 cites·10 claims
- 0760US2009311748A1Heart20049410 polypeptides and methods of making the sameACCELERON PHARMA INC·Filed 2009·Application pending·0 cites
- 0857US7560541B2Heart20049410 full-length cDNA and polypeptidesACCELERON PHARMA INC·Filed 2007·Granted Jul 14, 2009·0 cites·8 claims
- 0956US2017283494A1Human anti-il-33 neutralizing monoclonal antibodyMITSUBISHI TANABE PHARMA CORP·Filed 2017·Application pending·0 cites
- 1052US2006105376A1Novel full-length cDNARES ASS FOR BIOTECHNOLOGY·Filed 2005·Application pending·0 cites
- 1149US2007015163A1Novel full-length cDNARES ASS FOR BIOTECHNOLOGY·Filed 2005·Application pending·0 cites
- 1248US2006029945A1Novel full length cDNARES ASS FOR BIOTECHNOLOGY·Filed 2005·Application pending·0 cites
- 1341US2008260741A1Preventive and/or Therapeutic Agent for CancerMITSUBISHI PHARMA CORP·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tsutomu Yoshikawa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →